Nostrum Biodiscovery is a spin-off from the Barcelona Supercomputing Center and the Institute for Research in Biomedicine.
The company provides molecular modelling technologies focused on therapeutics and bio-based chemistry. Its customer-tailored solutions use proprietary and third-party software combined with AI.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Nostrum Biodiscovery has clients in more than 13 countries and is expanding in Asia and Latin America while strengthening its presence in the US and Europe.
The technologies focus on therapeutics—including small-molecule design, targeted protein degradation, antibodies, immunologics and nucleic acids—and bio-based chemistry such as enzyme engineering.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated August 31, 2026, September 6, 2026, September 11, 2026, September 13, 2026, September 14, 2026, September 15, 2026, September 18, 2026, September 19, 2026, September 21, 2026, September 26, 2026, September 27, 2026, September 28, 2026, September 30, 2026, October 7, 2026, October 8, 2026, October 9, 2026 and October 10, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.